Swiss exports to US surge in September as pharma shipments rise

Group 1 - Swiss exports to the United States increased by nearly 43% in September compared to the previous month, driven by pharmaceutical companies ramping up shipments ahead of U.S. tariffs [1] - Overall Swiss exports rose by 3.4% in September [1] - The pharmaceutical sector, which constitutes over half of Swiss goods exports, saw a 5.1% increase in exports in nominal terms in September [3] Group 2 - U.S. President Donald Trump imposed a 39% tariff on Switzerland in August, leading to a significant drop in Swiss exports that month, although pharmaceutical companies were initially exempted [2] - Starting October 1, a 100% tariff on branded or patented pharmaceutical products will be imposed unless companies establish manufacturing plants in the U.S. [2] - Major Swiss pharmaceutical companies like Roche and Novartis do not anticipate being affected by these U.S. measures due to their expansion plans in the country [3]